Login to Your Account

What's happening at Sinovac? Vaccine business disrupted by dispute over privatization

By Elise Mak
Staff Writer

Wednesday, May 16, 2018

HONG KONG – Nasdaq-listed Chinese vaccine maker Sinovac Biotech Ltd. is on the brink of collapse, as it is undergoing a series of events due to internal disputes concerning its privatization. The company has put its vaccine productions on hold, which may soon have an impact on its business.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription